SCHEMBL9165261

SCHEMBL9165261

CCCCCCCCCCCCCCCCCCOc1cc(OCCCOc2ccc(S(C)(=O)=O)cc2)cc(N(CC(=O)OC)CC(=O)OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.57
BLM P54132 1/20 0.57
MMP3 P08254 2/20 0.46
PTPN1 P18031 3/20 0.45
PLA2G4B P0C869 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
MMP2 P08253 2/20 0.42
CA9 Q16790 2/20 0.42
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
MMP9 P14780 1/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 2/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9172031 0.89 PLA2G2A (0.73) PLA2G2ABLMMMP3PLA2G4BTHRA
SCHEMBL9168532 0.86 PLA2G2A (0.74) PLA2G2ABLMTHRATHRBTSHR
SCHEMBL9169153 0.84 PLA2G2A (0.56) PLA2G2ABLMMMP3PLA2G4BTHRA
SCHEMBL9170245 0.84 PLA2G2A (0.58) PLA2G2ABLMPLA2G4BTSHRTP53
SCHEMBL9171634 0.82 PLA2G2A (0.85) PLA2G2ABLMPLA2G4BTHRATHRB
SCHEMBL9325310 0.81 PLA2G2A (0.52) PLA2G2AMMP3PLA2G4BNPC1RAB9A
SCHEMBL9168070 0.81 PLA2G2A (0.66) PLA2G2ABLMTHRATHRB
SCHEMBL9171261 0.79 PLA2G2A (0.64) PLA2G2ABLM
SCHEMBL9167296 0.79 PLA2G2A (0.64) PLA2G2ABLM
SCHEMBL9169041 0.79 PLA2G2A (0.59) PLA2G2ABLMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5446189-A Diester intermediates for diacid enzyme inhibitor HOFFMANN-LA ROCHE INC. (US) 1995-08-29 US disclosed
US-5324747-A Treatment of inflammatory diseases HOFFMANN-LA ROCHE INC. (US) 1994-06-28 US disclosed
EP-0579066-A2 N-substituted anilines F. HOFFMANN-LA ROCHE AG (CH) 1994-01-19 EP disclosed